The aim of this study was to establish reference values and factors associated with serum AFP elevation in infants. Five hundred twenty-four samples collected from infants up to the age of 2 years at the University Hospital Düsseldorf (Germany) were analyzed. At birth mean serum AFP levels were 41,687 ng/ml in 256 term babies and…
Pediatric Hematology and Oncology Template
Write in a clean editor, then format for Pediatric Hematology and Oncology in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Pediatric Hematology and Oncology format
Pediatric Hematology and Oncology is a peer-reviewed journal published by Taylor & Francis, covering Acute Lymphoblastic Leukemia research, Childhood Cancer Survivors' Quality of Life, Hemoglobinopathies and Related Disorders.
| Publisher | Taylor & Francis |
|---|---|
| Reference style | Author–year (Chicago, T&F) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Pediatric Hematology and Oncology 12 (3): 45–58.
Formats any DOI in Pediatric Hematology and Oncology style. No sign-up. |
| Publishes research in | Acute Lymphoblastic Leukemia research Childhood Cancer Survivors' Quality of Life Hemoglobinopathies and Related Disorders Acute Myeloid Leukemia Research Neuroblastoma Research and Treatments |
| ISSN | 0888-0018 |
| Citation impact (2-yr) | 1.03 |
| h-index | 62 |
| i10-index | 1,421 |
| Total citations | 41,275 |
| Top institutions publishing here | Hacettepe University |
| Journal website | www.informahealthcare.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Pediatric Hematology and Oncology per year
Citation impact of Pediatric Hematology and Oncology by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Pediatric Hematology and Oncology
Cisplatin in higher doses have been used routinely in the treatment of childhood tumours including neuroblastoma and germ cell tumors. Amifostine, a broad-spectrum cytoprotector of normal tissues, has been approved by U.S. Food and Drug Administration for use in patients receiving cisplatin. Such administration of amifostine has been reported to reduce cisplatin-related toxicities in some…
The incidence of leukemia is higher in children with Down syndrome (DS) than in normals. In approximately 50% of cases the type of leukemia is acute megakaryoblastic leukemia (AMKL) and it occurs during the first 4 years of life. The leukemic cell also has features of erythroid progenitors and therefore appears to be a precursor…
In spite of being one of the most investigated subjects among supportive care in cancer, no therapy has been found effective in treatment of chemotherapy-induced oral mucositis. Based on the observations that honey bees products have anti-inflammatory and wound healing effects, the present study tried to evaluate the effect of topical application of honey and…
Ewing sarcoma, a rare malignancy of childhood and adolescence, has become a model of advances in diagnosis, treatment, and outcome through long-standing research efforts in multinational clinical trials. With modern multimodal regimens consisting of local surgery and/or radiotherapy plus intensive systemic chemotherapy, survival can be achieved for ≈ 70% of patients with localized disease. However,…